vs
NVE CORP（NVEC）与Profound Medical Corp.（PROF）财务数据对比。点击上方公司名可切换其他公司
NVE CORP的季度营收约是Profound Medical Corp.的1.0倍（$6.2M vs $6.0M），NVE CORP净利率更高（54.4% vs -136.8%，领先191.1%）
NVE公司是一家专注于自旋电子元件研发和生产的科技企业，核心产品包括磁阻传感器、耦合器及信号隔离器，广泛应用于工业自动化、汽车电子、医疗设备及物联网领域，客户覆盖全球多家原始设备制造商与电子元件分销商。
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
NVEC vs PROF — 直观对比
营收规模更大
NVEC
是对方的1.0倍
$6.0M
净利率更高
NVEC
高出191.1%
-136.8%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.2M | $6.0M |
| 净利润 | $3.4M | $-8.2M |
| 毛利率 | 78.6% | 66.8% |
| 营业利润率 | 60.2% | -123.3% |
| 净利率 | 54.4% | -136.8% |
| 营收同比 | 22.9% | — |
| 净利润同比 | 11.0% | — |
| 每股收益（稀释后） | $0.70 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVECPROF
| Q4 25 | $6.2M | $6.0M | ||
| Q3 25 | $6.3M | $5.1M | ||
| Q2 25 | $6.1M | $2.0M | ||
| Q1 25 | $7.3M | $2.3M | ||
| Q4 24 | $5.1M | — | ||
| Q3 24 | $6.8M | — | ||
| Q2 24 | $6.8M | — | ||
| Q1 24 | $7.1M | — |
净利润NVECPROF
| Q4 25 | $3.4M | $-8.2M | ||
| Q3 25 | $3.3M | $-8.0M | ||
| Q2 25 | $3.6M | $-15.7M | ||
| Q1 25 | $3.9M | $-10.7M | ||
| Q4 24 | $3.0M | — | ||
| Q3 24 | $4.0M | — | ||
| Q2 24 | $4.1M | — | ||
| Q1 24 | $3.8M | — |
毛利率NVECPROF
| Q4 25 | 78.6% | 66.8% | ||
| Q3 25 | 78.3% | 77.7% | ||
| Q2 25 | 80.6% | 81.7% | ||
| Q1 25 | 79.2% | 79.2% | ||
| Q4 24 | 84.2% | — | ||
| Q3 24 | 86.0% | — | ||
| Q2 24 | 85.6% | — | ||
| Q1 24 | 75.5% | — |
营业利润率NVECPROF
| Q4 25 | 60.2% | -123.3% | ||
| Q3 25 | 57.6% | -176.2% | ||
| Q2 25 | 62.0% | -696.9% | ||
| Q1 25 | 58.4% | -477.0% | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 65.0% | — | ||
| Q2 24 | 64.7% | — | ||
| Q1 24 | 57.3% | — |
净利率NVECPROF
| Q4 25 | 54.4% | -136.8% | ||
| Q3 25 | 52.2% | -157.7% | ||
| Q2 25 | 58.6% | -792.3% | ||
| Q1 25 | 53.5% | -458.1% | ||
| Q4 24 | 60.2% | — | ||
| Q3 24 | 59.6% | — | ||
| Q2 24 | 60.4% | — | ||
| Q1 24 | 53.8% | — |
每股收益（稀释后）NVECPROF
| Q4 25 | $0.70 | $0.27 | ||
| Q3 25 | $0.68 | $0.26 | ||
| Q2 25 | $0.74 | $0.52 | ||
| Q1 25 | $0.80 | $0.36 | ||
| Q4 24 | $0.63 | — | ||
| Q3 24 | $0.83 | — | ||
| Q2 24 | $0.85 | — | ||
| Q1 24 | $0.78 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $20.6M | $59.7M |
| 总债务越低越好 | — | $4.5M |
| 股东权益账面价值 | $58.3M | $66.4M |
| 总资产 | $60.0M | $77.5M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资NVECPROF
| Q4 25 | $20.6M | $59.7M | ||
| Q3 25 | $17.7M | $24.8M | ||
| Q2 25 | $15.8M | $35.2M | ||
| Q1 25 | $21.7M | $46.4M | ||
| Q4 24 | $20.4M | — | ||
| Q3 24 | $22.9M | — | ||
| Q2 24 | $21.7M | — | ||
| Q1 24 | $22.2M | — |
总债务NVECPROF
| Q4 25 | — | $4.5M | ||
| Q3 25 | — | $4.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益NVECPROF
| Q4 25 | $58.3M | $66.4M | ||
| Q3 25 | $59.7M | $32.1M | ||
| Q2 25 | $61.1M | $39.3M | ||
| Q1 25 | $62.3M | $50.8M | ||
| Q4 24 | $63.0M | — | ||
| Q3 24 | $64.9M | — | ||
| Q2 24 | $64.9M | — | ||
| Q1 24 | $65.6M | — |
总资产NVECPROF
| Q4 25 | $60.0M | $77.5M | ||
| Q3 25 | $61.5M | $42.3M | ||
| Q2 25 | $63.6M | $49.7M | ||
| Q1 25 | $64.3M | $60.9M | ||
| Q4 24 | $64.6M | — | ||
| Q3 24 | $65.9M | — | ||
| Q2 24 | $66.7M | — | ||
| Q1 24 | $66.8M | — |
负债/权益比NVECPROF
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.2M | $-6.6M |
| 自由现金流经营现金流 - 资本支出 | $-4.8M | — |
| 自由现金流率自由现金流/营收 | -77.0% | — |
| 资本支出强度资本支出/营收 | 144.3% | — |
| 现金转化率经营现金流/净利润 | 1.24× | — |
| 过去12个月自由现金流最近4个季度 | $-5.5M | — |
8季度趋势，按日历期对齐
经营现金流NVECPROF
| Q4 25 | $4.2M | $-6.6M | ||
| Q3 25 | $2.8M | $-9.6M | ||
| Q2 25 | $5.2M | $-13.7M | ||
| Q1 25 | $2.5M | $-8.3M | ||
| Q4 24 | $3.8M | — | ||
| Q3 24 | $2.1M | — | ||
| Q2 24 | $5.9M | — | ||
| Q1 24 | $3.1M | — |
自由现金流NVECPROF
| Q4 25 | $-4.8M | — | ||
| Q3 25 | $2.7M | — | ||
| Q2 25 | $4.1M | — | ||
| Q1 25 | $-7.5M | — | ||
| Q4 24 | $-6.3M | — | ||
| Q3 24 | $1.9M | — | ||
| Q2 24 | $4.9M | — | ||
| Q1 24 | — | — |
自由现金流率NVECPROF
| Q4 25 | -77.0% | — | ||
| Q3 25 | 42.9% | — | ||
| Q2 25 | 67.7% | — | ||
| Q1 25 | -103.7% | — | ||
| Q4 24 | -124.7% | — | ||
| Q3 24 | 28.5% | — | ||
| Q2 24 | 72.8% | — | ||
| Q1 24 | — | — |
资本支出强度NVECPROF
| Q4 25 | 144.3% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 17.3% | — | ||
| Q1 25 | 137.9% | — | ||
| Q4 24 | 200.6% | — | ||
| Q3 24 | 3.1% | — | ||
| Q2 24 | 13.5% | — | ||
| Q1 24 | 0.0% | — |
现金转化率NVECPROF
| Q4 25 | 1.24× | — | ||
| Q3 25 | 0.84× | — | ||
| Q2 25 | 1.45× | — | ||
| Q1 25 | 0.64× | — | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | 1.43× | — | ||
| Q1 24 | 0.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
